Extended Data Fig. 1 | The effect of the G12Ci treatment on KR AS signalling
across lung cancer cell lines. The indicated models were treated with
increasing concentrations of the G12Ci (ARS1620) for 2 h (top panels) or with
10 μM over time (bottom panels), and immunoblotted to determine the effect
on KR AS signalling intermediates. Key genetic alterations found at baseline in
the KR AS(G12C)-mutant cell lines used in this study are listed. A representative
of two independent experiments for each cell line is shown.